The insurance regulator IRDAI on Wednesday said it has come to its...
Category:
Pandemic
Latest
Munich Re partners with OneDegree to launch digital asset insurance in Hong Kong
OneInfinity is an insurance and technology product offering...
Private COVID vaccination centres can only up to Rs 150 as service charge on precaution dose
Serum Institute of India has cut the price of its Covishield...
India’s chronic disease burden helped fuel Covid-19’s brutal waves
For years India has faced an escalating non-communicable disease crisis as its middle-class expands and leads a more sedentary and affluent lifestyle. That makes them susceptible to ailments such as diabetes and heart disease that account for almost two-thirds of all deaths in the country. Those existing conditions may have allowed the coronavirus to do more damage, boosting cases and fatalities and potentially fueling the near collapse of India’s health system.
WHO to decide on authorising Indian-made vaccine
Dr. Mariangela Simao, a WHO assistant director-general for vaccines, says the UN health agency’s assessment of the Bharat Biotech vaccine was “quite advanced” and officials hoped for a decision by mid-September.
IAF sacks staffer for refusing to get vaccinated against COVID-19
“Across India, only nine personnel have refused to take the vaccine. All of them were given show-cause notice…one did not respond, so in view of the lack of response, his service is already terminated,” Vyas told the court.
He said as far as the vaccine, in general, is concerned, it is optional, but so far as the Air Force is concerned, it is now made a service condition, which is in continuation of the oath taken at the time of enrollment in the service. Also, it is imperative to see to it that the Force is not put in a vulnerable state, and it is required for personnel to mandatorily get vaccinated, he told the court.
Sputnik V only 83% effective against Delta
Antibody levels are a good predictor for how effective Moderna Inc’s COVID-19 vaccine is, according to a new study released on Tuesday, a finding which could help speed up future clinical trials for vaccines against the disease.
Intranasal vaccine blocks Covid, stops transmission in animal trials
The researchers found the animals showed complete protection from lung infection, inflammation and lesions following exposure to the SARS-CoV-2 virus.
The two doses of the vaccine were found to significantly reduce the virus “shedding” from the nose and lungs of the hamsters — suggesting the preventive has the potential to control infection at the site of inoculation, they said.
Kids sick with Covid are filling up hospitals in US
At least 81 children in the US died of Covid between March and July, according to the Centers for Disease Control and Prevention, and many doctors warn that the situation is likely to get worse.Further, Covid infections in kids is coupled with a rise in cases of a respiratory virus known as respiratory syncytial virus, or RSV, a highly contagious, flu-like illness, that is typically more likely to affect children and older adults. That has shrunk the bed space further in children’s hospitals and expanded on the unrelenting demand on doctors and nurses, the report said.
COVID-19 numbers in SE Asia plateaued over past month mainly due to cases in India remaining stable: WHO
The highest number of new cases were reported from India (278,631 new cases; 20.2 new cases per 100,000; 2 per cent decrease), Indonesia (225,635 new cases; 82.5 new cases per 100,000; 18 per cent decrease), and Thailand (141,191 new cases; 202.3 new cases per 100 000; 20 per cent increase).
In the region, the highest numbers of new deaths were reported from Indonesia (11,373 new deaths; 4.2 new deaths per 100,000; 9 percent decrease), India (3511 new deaths; 0.3 new deaths per 100,000; 8 percent decrease), and Myanmar (2045 new deaths; 3.8 new deaths per 100,000; 22 percent decrease).
A third of India Inc sees deterioration in financial health in June qtr: Report
A falling GST compliance score clearly indicates that the financial health of nearly one-third of businesses being monitored deteriorated in Q1 of FY22, suggesting higher risk levels in the quarter, said Kaushal Sampat, co-founder of Rubix, which is an analytics-based B2B risk management and monitoring platform.
Delta tears across US, cases and hospitalisations at six-month high
Nationwide, Covid-19 cases have averaged 100,000 for three days in a row, up 35 per cent over the past week, according to a Reuters tally of public health data. The surge of the disease was strongest in Louisiana, Florida and Arkansas.Hospitalisations rose 40 per cent and deaths, a lagging indicator, registered an 18 per cent uptick in the past week with the most fatalities by population in Arkansas.
COVID-19: India’s drug regulator approves study on mixing of Covaxin and Covishield doses
Separately, a recent study by the Indian Council of Medical Research (ICMR) involving 98 people, 18 of whom had inadvertently received Covishield as the first dose and Covaxin as the second in Uttar Pradesh, showed that combining these two COVID-19 vaccines elicited better immunogenicity than two doses of the same vaccine.
The study also found that immunisation with combination of Covishield and Covaxin was safe and the adverse effects were also found to be similar when compared to the same dose regimen.